Cite
HARVARD Citation
Cheadle, E. et al. (n.d.). A TLR7 agonist enhances the anti-tumour efficacy of obinutuzumab through an NK cell/CD4 dependent mechanism in a murine lymphoma model. European journal of cancer. pp. S211-. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Cheadle, E. et al. (n.d.). A TLR7 agonist enhances the anti-tumour efficacy of obinutuzumab through an NK cell/CD4 dependent mechanism in a murine lymphoma model. European journal of cancer. pp. S211-. [Online].